The hepatorenal protective effects of silymarin in cancer patients receiving chemotherapy: a randomized, placebo-controlled trial

• প্রধান লেখক: Safoora Sadat Erfanian (লেখক), Hourieh Ansari (লেখক), Shaghayegh Haghjooy Javanmard (লেখক), Zahra Amini (লেখক), Ali Hajigholami (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: BMC, 2024-09-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract Background Breast cancer is one of the most common diseases globally that may have side effects on liver and renal function. Pharmacological treatments to reduce adverse liver and renal effects are still limited. It has been proposed that silymarin may possess hepatoprotective and anti-infl...